Critchfield Kenneth L, Levy Kenneth N, Clarkin John F
New York-Presbyterian Hospital, Joan and Sanford I Weill Medical College of Cornell University, New York, NY, USA.
Psychiatr Q. 2007 Mar;78(1):15-24. doi: 10.1007/s11126-006-9023-x.
The Personality Disorder Institute/Borderline Personality Disorder Research Foundation randomized control trial (PDI/BPDRF RCT) is a randomized control trial comparing three treatments for borderline personality disorder (BPD). An important issue for any RCT is diagnostic reliability, demonstration of which is necessary to evaluate claims of a treatment's efficacy for a given population. The present paper examines the interrater reliability of Axis I and II disorders in the context of a high base rate of BPD features for participants referred for inclusion in the RCT. Our results indicate good to excellent levels of interrater reliability for all Axis I and II disorders in this context. Assessors were able to reliably diagnose BPD, exclusionary criteria, and comorbid diagnoses. This data is important for comparing findings and sample composition across different studies using similar sampling strategies, especially as treatments are increasingly being developed and tested for BPD.
人格障碍研究所/边缘型人格障碍研究基金会随机对照试验(PDI/BPDRF RCT)是一项比较三种治疗边缘型人格障碍(BPD)方法的随机对照试验。任何随机对照试验的一个重要问题是诊断可靠性,要评估一种治疗方法对特定人群的疗效,必须证明诊断可靠性。本文在转介参加随机对照试验的参与者中BPD特征高基线率的背景下,研究了轴I和轴II障碍的评定者间信度。我们的结果表明,在此背景下,所有轴I和轴II障碍的评定者间信度处于良好到优秀水平。评估者能够可靠地诊断BPD、排除标准和共病诊断。这些数据对于使用类似抽样策略比较不同研究的结果和样本组成非常重要,特别是随着针对BPD的治疗方法越来越多地被开发和测试。